Corporate Headquarters 

7070 Mississauga Road
Suite 350
Mississauga, Ontario L5N 7J8 
Canada

Phone: (905) 821-4001 
Toll Free: 888-728-4366 (888-PATHEON) 
Website: www.patheon.com 
Email: patheon@patheon.com
New:  Press Release

Number of Employees: 5,300+ 
Founded: 1974 
Number of Facilities:  14 (10 North American, 4 European)

Corporate Description

Patheon provides integrated dosage form development and contract manufacturing services to more than 250 of the world’s leading pharmaceutical, biotechnology and specialty pharmaceutical companies.

With more than 5,300 skilled employees and 3.2 million square feet of manufacturing capacity, our global manufacturing network comprises 14 facilities located in North America and Europe.

Patheon offers commercial manufacturing services for virtually all conventional dosage forms as well as specialized dosage forms such as cephalosporin, high-potency, controlled release and sterile manufacturing, including aseptic filling and lyophilization.

Patheon’s comprehensive range of integrated Pharmaceutical Development Services (PDS) offered from five dedicated development Centers of Excellence can rapidly advance your molecule to market.

Patheon offers STRATEGIC SOLUTIONS made SIMPLE™.

Products and Services

Patheon offers fully integrated development services in both North America and Europe. Pre-formulation, formulation, scale-up, analytical development and clinical manufacturing make up the comprehensive development services performed by nearly 500 experienced development scientists, including almost 70 PhDs.

Patheon provides core manufacturing for both prescription (Rx) and consumer (OTC) pharmaceutical products.  Our turn-key manufacturing capabilities cover virtually all finished dosage forms including parenteral, solid, semi-solid and liquid formats.

We also offer specialized formats and capabilities such as liquid-filled hard capsules, controlled release, cephalosporin, high-potency, and sterile manufacturing, including aseptic filling and lyophilization.

Markets served

Patheon currently manufactures over 700 products for more than 250 pharmaceutical and biotechnology clients around the world.  These organizations include 19 of the world’s top 20 largest multinational pharmaceutical companies, seven of the top 20 biotechnology companies and seven of the top 20 specialty pharmaceutical companies.

Financial

Patheon Inc. is a Canadian public company, which trades under the symbol PTI on the Toronto Stock Exchange.  Revenues (before repositioning costs) for the year ended October 31, 2006 were USD $712 versus revenues of USD $698 in 2005.

Press Release